Next Article in Journal
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
Next Article in Special Issue
Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection
Previous Article in Journal
Ways into Understanding HIF Inhibition
Previous Article in Special Issue
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2021, 13(1), 160; https://doi.org/10.3390/cancers13010160
Action Date Notes Link
article pdf uploaded. 5 January 2021 15:23 CET Version of Record https://www.mdpi.com/2072-6694/13/1/160/pdf-vor
article supplementary file uploaded. 5 January 2021 15:23 CET - https://www.mdpi.com/2072-6694/13/1/160#supplementary
article xml file uploaded 7 January 2021 10:33 CET Original file -
article xml uploaded. 7 January 2021 10:33 CET Update https://www.mdpi.com/2072-6694/13/1/160/xml
article pdf uploaded. 7 January 2021 10:33 CET Updated version of record https://www.mdpi.com/2072-6694/13/1/160/pdf
article html file updated 7 January 2021 10:34 CET Original file -
article html file updated 23 July 2022 10:43 CEST Update https://www.mdpi.com/2072-6694/13/1/160/html
Back to TopTop